[1] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺功能亢进症.中华内科杂志, 2007, 46(10): 876-882.
[2] Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthahnol, 1995, 119(6): 792-795.
[3] 孟召伟, 谭建.解读美国甲状腺学会和临床内分泌医师协会2011年甲亢诊治指南.国际放射医学核医学杂志, 2011, 35(4): 193-201.
[4] 吕红彬, 黄新文, 罗清礼, 等. CT在甲状腺相关眼病中的诊断价值.四川大学学报:医学版, 2007, 38(1): l67-l69.
[5] Marcocci C, Bartalena L, Bogazzi F, et al. Studies on the occurrence of ophthalmopathy in Graves'disease. Acta Endocrinol, 1989, 120(4): 473-478.
[6] Brent GA. Graves' disease. N Engl J Med, 2008, 358(24): 2594-2605.
[7] Subekti I, Boedisantoso A, Moeloek ND, et al. Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy. Acta Med Indones, 2012, 44(2): 114-121.
[8]

陆再英, 钟南山.内科学. 7版.北京:人民卫生出版社, 2008: 717.
[9] Crisp MS, Lane C, Halliwell M, et al. Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab, 1997, 82(6): 2003-2005.
[10] Feliciello A, Porcellini A, Ciullo I, et al. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet, 1993, 342(8867): 337-338.
[11] Boschi A, Daumerie Ch, Spiritus M, et al. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol, 2005, 89(6): 724-729.
[12] 宋补昌, 李宝兰, 孙斌.血清TRAb检测对Graves病突眼的应用价值.放射免疫学杂志, 2005, 18(6): 478-479.
[13] 唐武儒, 韦南仕. TRAb水平测定在甲亢并突眼治疗中的意义探讨.右江民族医学院学报, 2006, 28(1): 56.
[14] 王亚萍, 肖锦华, 朱华燕, 等.全自动电化学发光免疫分析法检测血清TRAb的方法学评价.放射免疫学杂志, 2011, 24(6): 661-664.
[15] 何建华, 曾钦文. TSH受体抗体及临床意义.国外医学:放射医学核医学分册, 2001, 25(3): 111-114.